TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
RSA Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
371
|
417
|
437 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
175
|
249
|
177 |
| EBITDA |
171
|
201
|
184 |
| Total assets |
440
|
454
|
361 |
| Current assets |
423
|
430
|
330 |
| Current liabilities |
140
|
122
|
138 |
| Equity capital |
261
|
300
|
200 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
59.3%
|
66.1%
|
55.4% |
| Turnover per employee |
186
|
208
|
218 |
| Profit as a percentage of turnover |
47.2%
|
59.7%
|
40.5% |
| Return on assets (ROA) |
39.8%
|
54.8%
|
49.0% |
| Current ratio |
302.1%
|
352.5%
|
239.1% |
| Return on equity (ROE) |
67.0%
|
83.0%
|
88.5% |
| Change turnover |
-32
|
-21
|
-77 |
| Change turnover % |
-8%
|
-5%
|
-15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.